Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Senate Finance Committee Approves Increased Generic Manufacturer Rebates

This article was originally published in The Pink Sheet Daily

Executive Summary

The Medicaid reform provision was marked up within budget reconciliation legislation that otherwise remained unchanged.
Advertisement

Related Content

Increased Medicaid Rebates Will Not Significantly Change Generic Manufacturer Participation, CBO Says
Increased Medicaid Rebates Will Not Significantly Change Generic Manufacturer Participation, CBO Says
House Medicaid Reform Limits Antipsychotic/Antidepressant Prior Authorization
House Medicaid Reform Limits Antipsychotic/Antidepressant Prior Authorization
House Medicaid Reform Would Include Minimum Dispensing Fee For Generics
Senate Finance Committee Proposes Including “Authorized” Generics In “Best Price”
Senate Finance Committee Proposes Including “Authorized” Generics In “Best Price”

Topics

Advertisement
UsernamePublicRestriction

Register

PS061168

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel